<p>核心實驗室（NYSE:CLB - 獲取免費報告）在週三更新了 2026 年第二季度的盈利指引。該公司提供的每股收益指引為 0.060-0.120，而市場共識的每股收益預期為 0.150。該公司發佈的收入指引為 1.23 億至 1.31 億美元，而市場共識的收入預期為 1.278 億美元。</p>
<p>獲取 <strong>核心實驗室</strong> 的提醒：</p>
<h2>分析師升級和降級</h2>
<ul>
<li>MarketBeat ‘本週股票’：哈里伯頓是一項出色的石油投資</li>
</ul>
<p>另外，Weiss Ratings 在 3 月 27 日的報告中重申了對核心實驗室股票的 “持有（c）” 評級。四位分析師對該股票給予了持有評級，根據 MarketBeat 的數據，該公司目前的平均評級為 “持有”，平均目標價格為 12.50 美元。</p>
<p><strong>查看我們關於核心實驗室的最新研究報告</strong></p>
<h2>核心實驗室股票上漲 2.6%</h2>
<p>在週三的午盤交易中，CLB 股票上漲了 0.44 美元，達到 17.21 美元。該公司的交易量為 512,329 股，而其平均交易量為 384,367 股。該公司的市值為 7.9238 億美元，市盈率為 25.68，PEG 比率為 3.25，貝塔值為 1.15。該公司的 50 日移動平均線為 16.76 美元，200 日移動平均線為 16.69 美元。該公司的流動比率為 2.02，速動比率為 1.51，債務與股本比率為 0.41。核心實驗室的 1 年最低價為 9.72 美元，1 年最高價為 20.36 美元。</p>
<p>核心實驗室（NYSE:CLB - 獲取免費報告）最後一次發佈季度財報是在 4 月 29 日。該石油和天然氣公司報告的每股收益為 0.06 美元，低於分析師共識預期的 0.11 美元，差額為 0.05 美元。核心實驗室的淨利潤率為 6.04%，股本回報率為 12.18%。核心實驗室已將其 2026 年第二季度的指引設定為 0.060-0.120 每股收益。平均而言，股票研究分析師預計核心實驗室在當前財政年度將發佈 0.57 美元的每股收益。</p>
<h2>核心實驗室分紅公告</h2>
<p>該公司最近還宣佈了一項季度分紅，該分紅於 3 月 9 日星期一支付。2 月 16 日的股東獲得了每股 0.01 美元的分紅。這代表着每年 0.04 美元的分紅和 0.2% 的分紅收益率。除息日期為 2 月 13 日星期五。核心實驗室的派息比率為 5.97%。</p>
<h2>核心實驗室的機構交易</h2>
<p>機構投資者最近對該公司的持倉進行了調整。Platinum Investment Management Ltd.在第三季度將其在核心實驗室的持倉增加了 3.9%。Platinum Investment Management Ltd.目前擁有 23,758 股該石油和天然氣公司的股票，價值 294,000 美元，此前在上個季度增持了 889 股。Sei Investments Co.在第二季度收購了核心實驗室的新股份，價值約 231,000 美元。Corient Private Wealth LLC 在第四季度收購了核心實驗室的新股份，價值約 219,000 美元。Manufacturers Life Insurance Company 在第二季度將其在核心實驗室的持倉增加了 6.2%。Manufacturers Life Insurance Company 目前擁有 17,932 股該石油和天然氣公司的股票，價值 207,000 美元，此前在上個季度增持了 1,040 股。最後，iSAM Funds UK Ltd 在第三季度收購了核心實驗室的新股份，價值約 202,000 美元。目前 97.81% 的股票由機構投資者和對沖基金持有。</p>
<h2>關於核心實驗室</h2>
<p>（獲取免費報告）</p>
<p>核心實驗室 N.V.是全球領先的專有和專利儲層描述及生產增強服務提供商，服務於石油和天然氣行業。該公司運用在岩心和流體分析、先進的岩石物理解釋和儲層工程方面的專業知識，以優化碳氫化合物的回收。通過將實驗室測試與現場服務和數字分析相結合，核心實驗室提供的見解幫助運營商最大化生產並延長資產的使用壽命。</p>
<p>該公司的產品組合涵蓋兩個主要服務領域：儲層描述和生產增強。</p>
<h2>瞭解更多</h2>
<ul>
<li>我們更看好的五隻股票，而不是核心實驗室</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsEstimatesChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNMQg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsEstimatesChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNMQg"/></p>
<p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 1000 美元在核心實驗室嗎？</h2>
<p>在你考慮核心實驗室之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦的股票。MarketBeat 已識別出五隻頂級分析師正在悄悄向客户推薦的股票，以便在更廣泛的市場注意到之前購買……而核心實驗室並不在名單上。</p>
<p>雖然核心實驗室目前在分析師中獲得了持有評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

岩心實驗室

<p>Core Laboratories（紐約證券交易所代碼：CLB）更新了其 2026 年第二季度的盈利指引，預計每股收益（EPS）在 0.060 至 0.120 之間，低於市場共識預期的 0.150。收入指引設定在 1.23 億美元至 1.31 億美元之間，而市場共識為 1.278 億美元。該股最近上漲了 2.6%，報 17.21 美元，分析師的平均評級為 “持有”。公司還宣佈每股季度分紅為 0.01 美元。機構投資者持有該股的 97.81%，反映出機構對公司的強烈興趣</p>

<p>Core Laboratories (NYSE:CLB - Get Free Report) updated its second quarter 2026 earnings guidance on Wednesday. The company provided EPS guidance of 0.060-0.120 for the period, compared to the consensus EPS estimate of 0.150. The company issued revenue guidance of $123.0 million-$131.0 million, compared to the consensus revenue estimate of $127.8 million.</p>
<div class="lb-trans"><p>核心實驗室（NYSE:CLB - 獲取免費報告）在週三更新了 2026 年第二季度的盈利指引。該公司提供的每股收益指引為 0.060-0.120，而市場共識的每股收益預期為 0.150。該公司發佈的收入指引為 1.23 億至 1.31 億美元，而市場共識的收入預期為 1.278 億美元。</p>
</div><p>Get <strong>Core Laboratories</strong> alerts:</p>
<div class="lb-trans"><p>獲取 <strong>核心實驗室</strong> 的提醒：</p>
</div><h2>Analyst Upgrades and Downgrades</h2>
<div class="lb-trans"><h2>分析師升級和降級</h2>
</div><ul>
<li>MarketBeat ‘Stock of the Week’: Halliburton Is One Slick Oil Play</li>
</ul>
<div class="lb-trans"><ul>
<li>MarketBeat ‘本週股票’：哈里伯頓是一項出色的石油投資</li>
</ul>
</div><p>Separately, Weiss Ratings restated a &#34;hold (c)&#34; rating on shares of Core Laboratories in a report on Friday, March 27th. Four analysts have rated the stock with a Hold rating, Based on data from MarketBeat, the company currently has an average rating of &#34;Hold&#34; and an average target price of $12.50.</p>
<div class="lb-trans"><p>另外，Weiss Ratings 在 3 月 27 日的報告中重申了對核心實驗室股票的 “持有（c）” 評級。四位分析師對該股票給予了持有評級，根據 MarketBeat 的數據，該公司目前的平均評級為 “持有”，平均目標價格為 12.50 美元。</p>
</div><p><strong>View Our Latest Research Report on Core Laboratories</strong></p>
<div class="lb-trans"><p><strong>查看我們關於核心實驗室的最新研究報告</strong></p>
</div><h2>Core Laboratories Stock Up 2.6%</h2>
<div class="lb-trans"><h2>核心實驗室股票上漲 2.6%</h2>
</div><p>CLB stock traded up $0.44 during midday trading on Wednesday, reaching $17.21. The company had a trading volume of 512,329 shares, compared to its average volume of 384,367. The company has a market capitalization of $792.38 million, a P/E ratio of 25.68, a PEG ratio of 3.25 and a beta of 1.15. The company has a 50 day moving average of $16.76 and a two-hundred day moving average of $16.69. The company has a current ratio of 2.02, a quick ratio of 1.51 and a debt-to-equity ratio of 0.41. Core Laboratories has a 1 year low of $9.72 and a 1 year high of $20.36.</p>
<div class="lb-trans"><p>在週三的午盤交易中，CLB 股票上漲了 0.44 美元，達到 17.21 美元。該公司的交易量為 512,329 股，而其平均交易量為 384,367 股。該公司的市值為 7.9238 億美元，市盈率為 25.68，PEG 比率為 3.25，貝塔值為 1.15。該公司的 50 日移動平均線為 16.76 美元，200 日移動平均線為 16.69 美元。該公司的流動比率為 2.02，速動比率為 1.51，債務與股本比率為 0.41。核心實驗室的 1 年最低價為 9.72 美元，1 年最高價為 20.36 美元。</p>
</div><p>Core Laboratories (NYSE:CLB - Get Free Report) last released its quarterly earnings results on Wednesday, April 29th. The oil and gas company reported $0.06 earnings per share for the quarter, missing analysts' consensus estimates of $0.11 by ($0.05). Core Laboratories had a net margin of 6.04% and a return on equity of 12.18%. Core Laboratories has set its Q2 2026 guidance at 0.060-0.120 EPS. On average, equities research analysts expect that Core Laboratories will post 0.57 earnings per share for the current fiscal year.</p>
<div class="lb-trans"><p>核心實驗室（NYSE:CLB - 獲取免費報告）最後一次發佈季度財報是在 4 月 29 日。該石油和天然氣公司報告的每股收益為 0.06 美元，低於分析師共識預期的 0.11 美元，差額為 0.05 美元。核心實驗室的淨利潤率為 6.04%，股本回報率為 12.18%。核心實驗室已將其 2026 年第二季度的指引設定為 0.060-0.120 每股收益。平均而言，股票研究分析師預計核心實驗室在當前財政年度將發佈 0.57 美元的每股收益。</p>
</div><h2>Core Laboratories Dividend Announcement</h2>
<div class="lb-trans"><h2>核心實驗室分紅公告</h2>
</div><p>The firm also recently announced a quarterly dividend, which was paid on Monday, March 9th. Stockholders of record on Monday, February 16th were given a dividend of $0.01 per share. This represents a $0.04 annualized dividend and a dividend yield of 0.2%. The ex-dividend date was Friday, February 13th. Core Laboratories's payout ratio is 5.97%.</p>
<div class="lb-trans"><p>該公司最近還宣佈了一項季度分紅，該分紅於 3 月 9 日星期一支付。2 月 16 日的股東獲得了每股 0.01 美元的分紅。這代表着每年 0.04 美元的分紅和 0.2% 的分紅收益率。除息日期為 2 月 13 日星期五。核心實驗室的派息比率為 5.97%。</p>
</div><h2>Institutional Trading of Core Laboratories</h2>
<div class="lb-trans"><h2>核心實驗室的機構交易</h2>
</div><p>Institutional investors have recently made changes to their positions in the business. Platinum Investment Management Ltd. boosted its position in shares of Core Laboratories by 3.9% during the 3rd quarter. Platinum Investment Management Ltd. now owns 23,758 shares of the oil and gas company's stock valued at $294,000 after acquiring an additional 889 shares in the last quarter. Sei Investments Co. acquired a new stake in shares of Core Laboratories during the 2nd quarter valued at about $231,000. Corient Private Wealth LLC acquired a new stake in shares of Core Laboratories during the 4th quarter valued at about $219,000. The Manufacturers Life Insurance Company boosted its position in shares of Core Laboratories by 6.2% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 17,932 shares of the oil and gas company's stock valued at $207,000 after acquiring an additional 1,040 shares in the last quarter. Finally, iSAM Funds UK Ltd acquired a new stake in shares of Core Laboratories during the 3rd quarter valued at about $202,000. 97.81% of the stock is currently owned by institutional investors and hedge funds.</p>
<div class="lb-trans"><p>機構投資者最近對該公司的持倉進行了調整。Platinum Investment Management Ltd.在第三季度將其在核心實驗室的持倉增加了 3.9%。Platinum Investment Management Ltd.目前擁有 23,758 股該石油和天然氣公司的股票，價值 294,000 美元，此前在上個季度增持了 889 股。Sei Investments Co.在第二季度收購了核心實驗室的新股份，價值約 231,000 美元。Corient Private Wealth LLC 在第四季度收購了核心實驗室的新股份，價值約 219,000 美元。Manufacturers Life Insurance Company 在第二季度將其在核心實驗室的持倉增加了 6.2%。Manufacturers Life Insurance Company 目前擁有 17,932 股該石油和天然氣公司的股票，價值 207,000 美元，此前在上個季度增持了 1,040 股。最後，iSAM Funds UK Ltd 在第三季度收購了核心實驗室的新股份，價值約 202,000 美元。目前 97.81% 的股票由機構投資者和對沖基金持有。</p>
</div><h2>About Core Laboratories</h2>
<div class="lb-trans"><h2>關於核心實驗室</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（獲取免費報告）</p>
</div><p>Core Laboratories N.V. is a global provider of proprietary and patented reservoir description and production enhancement services to the oil and gas industry. The company applies specialized expertise in core and fluid analysis, advanced petrophysical interpretation, and reservoir engineering to optimize hydrocarbon recovery. By integrating laboratory testing with field services and digital analytics, Core Laboratories delivers insights that help operators maximize production and extend the life of their assets.</p>
<div class="lb-trans"><p>核心實驗室 N.V.是全球領先的專有和專利儲層描述及生產增強服務提供商，服務於石油和天然氣行業。該公司運用在岩心和流體分析、先進的岩石物理解釋和儲層工程方面的專業知識，以優化碳氫化合物的回收。通過將實驗室測試與現場服務和數字分析相結合，核心實驗室提供的見解幫助運營商最大化生產並延長資產的使用壽命。</p>
</div><p>The company's portfolio spans two primary service lines: reservoir description and production enhancement.</p>
<div class="lb-trans"><p>該公司的產品組合涵蓋兩個主要服務領域：儲層描述和生產增強。</p>
</div><h2>Read More</h2>
<div class="lb-trans"><h2>瞭解更多</h2>
</div><ul>
<li>Five stocks we like better than Core Laboratories</li>
</ul>
<div class="lb-trans"><ul>
<li>我們更看好的五隻股票，而不是核心實驗室</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsEstimatesChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNMQg" alt="" original-src="https://www.marketbeat.com/scripts/EarningsEstimatesChart.ashx?Prefix=NYSE&amp;Symbol=CLB"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Core Laboratories Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1000 美元在核心實驗室嗎？</h2>
</div><p>Before you consider Core Laboratories, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考慮核心實驗室之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Core Laboratories wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦的股票。MarketBeat 已識別出五隻頂級分析師正在悄悄向客户推薦的股票，以便在更廣泛的市場注意到之前購買……而核心實驗室並不在名單上。</p>
</div><p>While Core Laboratories currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然核心實驗室目前在分析師中獲得了持有評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

岩心實驗室（NYSE:CLB）發佈 2026 年第二季度業績指引